Alnylam Pharmaceuticals | ALNY - 流动负债

股票价格

318.85

每天变化

-9.88 -3.01%

每月一次

0.06%

每年

21.62%

Q2 预测

309.25

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 41.13B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	流动负债	更改		日
Acadia Pharmaceuticals	USD 277.11M		79.47M	2025-12
Agios Pharmaceuticals	USD 82.21M		7.45M	2025-12
Alnylam Pharmaceuticals	USD 1.47B		89.13M	2025-12
Amgen	USD 25.49B		3.7B	2025-12
Arrowhead Research	USD 347.42M		151.94M	2025-12
BioCryst Pharmaceuticals	USD 196.07M		5.83M	2025-12
BioMarin Pharmaceutical	USD 759.03M		39.41M	2025-12
Incyte	USD 1.52B		176.44M	2025-12
Ionis Pharmaceuticals	USD 783M		120.46M	2025-12
Moderna	USD 1.99B		306M	2025-12
Neurocrine Biosciences	USD 743.4M		105.4M	2025-12
Novartis	USD 27.28B		4.72B	2025-12
PTC Therapeutics	USD 968.43M		102.18M	2025-12
Regeneron Pharmaceuticals	USD 4.37B		56.7M	2025-12
Sangamo BioSciences	USD 47.66M		1.9M	2025-06
Sanofi	EUR 28.35B		9.32B	2025-12
Sarepta Therapeutics	USD 1.1B		173.86M	2025-12
Takeda	JPY 2.61T		470.53B	2025-12
Tectonic Therapeutic	USD 9.67M		293K	2025-12
Ultragenyx Pharmaceutical	USD 340.02M		46.78M	2025-09
Vertex Pharmaceuticals	USD 3.86B		614.1M	2025-12
Xencor	USD 95.91M		9.42M	2025-12